Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection

Marco Frigeni; Caroline Besson; Carlo Visco; Helene Fontaine; Maria Goldaniga; Marcella Visentini; Alessandro Pulsoni; Harrys A. Torres; Jan Peveling-Oberhag; Roberto Rossotti; Francesco Zaja; Luigi Rigacci; Michele Merli; Céline Dorival; Camille Alric; Francesco Piazza; Massimo Gentile; Angela Ferrari; Mario Pirisi; Luca Nassi; Sara Rattotti; Annamaria Frustaci; Michele Milella; Emanuele Cencini; Irene Defrancesco; Virginia Valeria Ferretti; Raffaele Bruno; Olivier Hermine; Luca Arcaini

doi:10.1038/s41375-019-0687-2

Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection

Marco Frigeni, Caroline Besson, Carlo Visco, Helene Fontaine, Maria Goldaniga, Marcella Visentini, Alessandro Pulsoni, Harrys A. Torres, Jan Peveling-Oberhag, Roberto Rossotti, Francesco Zaja, Luigi Rigacci, Michele Merli, Céline Dorival, Camille Alric, Francesco Piazza, Massimo Gentile, Angela Ferrari, Mario Pirisi, Luca NassiSara Rattotti, Annamaria Frustaci, Michele Milella, Emanuele Cencini, Irene Defrancesco, Virginia Valeria Ferretti, Raffaele Bruno, Olivier Hermine, Luca Arcaini

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Lingua originale	Inglese
pagine (da-a)	1462-1466
Numero di pagine	5
Rivista	Leukemia
Volume	34
Numero di pubblicazione	5
DOI	https://doi.org/10.1038/s41375-019-0687-2
Stato di pubblicazione	Pubblicato - 1 mag 2020

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1038/s41375-019-0687-2

Altri file e collegamenti

Link to publication in Scopus

Cita questo

Frigeni, M., Besson, C., Visco, C., Fontaine, H., Goldaniga, M., Visentini, M., Pulsoni, A., Torres, H. A., Peveling-Oberhag, J., Rossotti, R., Zaja, F., Rigacci, L., Merli, M., Dorival, C., Alric, C., Piazza, F., Gentile, M., Ferrari, A., Pirisi, M., ... Arcaini, L. (2020). Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Leukemia, 34(5), 1462-1466. https://doi.org/10.1038/s41375-019-0687-2

@article{96dba431494f4dbf9cd9c09c15f900a8,

title = "Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection",

author = "Marco Frigeni and Caroline Besson and Carlo Visco and Helene Fontaine and Maria Goldaniga and Marcella Visentini and Alessandro Pulsoni and Torres, {Harrys A.} and Jan Peveling-Oberhag and Roberto Rossotti and Francesco Zaja and Luigi Rigacci and Michele Merli and C{\'e}line Dorival and Camille Alric and Francesco Piazza and Massimo Gentile and Angela Ferrari and Mario Pirisi and Luca Nassi and Sara Rattotti and Annamaria Frustaci and Michele Milella and Emanuele Cencini and Irene Defrancesco and Ferretti, {Virginia Valeria} and Raffaele Bruno and Olivier Hermine and Luca Arcaini",

note = "Funding Information: Funding The research leading to these results has received funding from AIRC under IG 2017—ID. 20767 project—P.I. Luca Arcaini and from “Ricerca Corrente Fondazione IRCCS Policlinico San Matteo”— P.I. Luca Arcaini. The ANRS-CO22 HEPATHER cohort was sponsored and funded by ANRS (France REcherche Nord & Sud Sida-HIV H{\'e}patites). The sponsor has not participated in the statistical analysis and interpretation of data, in the writing the manuscript, and in the decision to submit the work for publication.",

year = "2020",

month = may,

day = "1",

doi = "10.1038/s41375-019-0687-2",

language = "English",

volume = "34",

pages = "1462--1466",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "5",

}

Frigeni, M, Besson, C, Visco, C, Fontaine, H, Goldaniga, M, Visentini, M, Pulsoni, A, Torres, HA, Peveling-Oberhag, J, Rossotti, R, Zaja, F, Rigacci, L, Merli, M, Dorival, C, Alric, C, Piazza, F, Gentile, M, Ferrari, A, Pirisi, M, Nassi, L, Rattotti, S, Frustaci, A, Milella, M, Cencini, E, Defrancesco, I, Ferretti, VV, Bruno, R, Hermine, O & Arcaini, L 2020, 'Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection', Leukemia, vol. 34, n. 5, pagg. 1462-1466. https://doi.org/10.1038/s41375-019-0687-2

Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection. / Frigeni, Marco; Besson, Caroline; Visco, Carlo et al.
In: Leukemia, Vol. 34, N. 5, 01.05.2020, pag. 1462-1466.

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

TY - JOUR

T1 - Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection

AU - Frigeni, Marco

AU - Besson, Caroline

AU - Visco, Carlo

AU - Fontaine, Helene

AU - Goldaniga, Maria

AU - Visentini, Marcella

AU - Pulsoni, Alessandro

AU - Torres, Harrys A.

AU - Peveling-Oberhag, Jan

AU - Rossotti, Roberto

AU - Zaja, Francesco

AU - Rigacci, Luigi

AU - Merli, Michele

AU - Dorival, Céline

AU - Alric, Camille

AU - Piazza, Francesco

AU - Gentile, Massimo

AU - Ferrari, Angela

AU - Pirisi, Mario

AU - Nassi, Luca

AU - Rattotti, Sara

AU - Frustaci, Annamaria

AU - Milella, Michele

AU - Cencini, Emanuele

AU - Defrancesco, Irene

AU - Ferretti, Virginia Valeria

AU - Bruno, Raffaele

AU - Hermine, Olivier

AU - Arcaini, Luca

N1 - Funding Information: Funding The research leading to these results has received funding from AIRC under IG 2017—ID. 20767 project—P.I. Luca Arcaini and from “Ricerca Corrente Fondazione IRCCS Policlinico San Matteo”— P.I. Luca Arcaini. The ANRS-CO22 HEPATHER cohort was sponsored and funded by ANRS (France REcherche Nord & Sud Sida-HIV Hépatites). The sponsor has not participated in the statistical analysis and interpretation of data, in the writing the manuscript, and in the decision to submit the work for publication.

PY - 2020/5/1

Y1 - 2020/5/1

UR - http://www.scopus.com/inward/record.url?scp=85076354532&partnerID=8YFLogxK

U2 - 10.1038/s41375-019-0687-2

DO - 10.1038/s41375-019-0687-2

M3 - Article

SN - 0887-6924

VL - 34

SP - 1462

EP - 1466

JO - Leukemia

JF - Leukemia

IS - 5

ER -